These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36186744)

  • 1. Growth differentiation factor 15 as an emerging novel biomarker in SARS-CoV-2 infection.
    Parchwani D; Dholariya S; Katoch C; Singh R
    World J Methodol; 2022 Sep; 12(5):438-447. PubMed ID: 36186744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19.
    Myhre PL; Prebensen C; Strand H; Røysland R; Jonassen CM; Rangberg A; Sørensen V; Søvik S; Røsjø H; Svensson M; Berdal JE; Omland T
    Circulation; 2020 Dec; 142(22):2128-2137. PubMed ID: 33058695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth Differentiation Factor 15 (GDF-15): A Novel Biomarker Associated with Poorer Respiratory Function in COVID-19.
    Alserawan L; Peñacoba P; Orozco Echevarría SE; Castillo D; Ortiz E; Martínez-Martínez L; Moga Naranjo E; Domingo P; Castellví I; Juárez C; Mariscal A
    Diagnostics (Basel); 2021 Oct; 11(11):. PubMed ID: 34829345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics validate circulating GDF-15 as an independent biomarker for COVID-19 severity.
    Bu S; Royston L; Mabanga T; Berini CA; Tremblay C; Lebouché B; Cox J; Costiniuk CT; Durand M; Isnard S; Routy JP
    Front Immunol; 2024; 15():1377126. PubMed ID: 38686386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coping With Stress: The Mitokine GDF-15 as a Biomarker of COVID-19 Severity.
    Ahmed DS; Isnard S; Berini C; Lin J; Routy JP; Royston L
    Front Immunol; 2022; 13():820350. PubMed ID: 35251002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome.
    Wollert KC; Kempf T; Peter T; Olofsson S; James S; Johnston N; Lindahl B; Horn-Wichmann R; Brabant G; Simoons ML; Armstrong PW; Califf RM; Drexler H; Wallentin L
    Circulation; 2007 Feb; 115(8):962-71. PubMed ID: 17283261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine Elevation in Severe COVID-19 From Longitudinal Proteomics Analysis: Comparison With Sepsis.
    Ebihara T; Matsumoto H; Matsubara T; Togami Y; Nakao S; Matsuura H; Kojima T; Sugihara F; Okuzaki D; Hirata H; Yamamura H; Ogura H
    Front Immunol; 2021; 12():798338. PubMed ID: 35095877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Angiotensin-Converting Enzyme 2 as a Prognostic Biomarker for Disease Progression in Patients Infected with SARS-CoV-2.
    Díaz-Troyano N; Gabriel-Medina P; Weber S; Klammer M; Barquín-DelPino R; Castillo-Ribelles L; Esteban A; Hernández-González M; Ferrer-Costa R; Pumarola T; Rodríguez-Frías F
    Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35453934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumonia Severity Index and CURB-65 Score Are Good Predictors of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia.
    Bradley J; Sbaih N; Chandler TR; Furmanek S; Ramirez JA; Cavallazzi R
    Chest; 2022 Apr; 161(4):927-936. PubMed ID: 34740594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
    Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
    Front Immunol; 2020; 11():581338. PubMed ID: 33123167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth Differentiation Factor-15 as a Predictor of Idiopathic Membranous Nephropathy Progression: A Retrospective Study.
    Ham YR; Song CH; Bae HJ; Jeong JY; Yeo MK; Choi DE; Na KR; Lee KW
    Dis Markers; 2018; 2018():1463940. PubMed ID: 29682097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
    Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
    J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth differentiation factor-15 and prognosis in acute respiratory distress syndrome: a retrospective cohort study.
    Clark BJ; Bull TM; Benson AB; Stream AR; Macht M; Gaydos J; Meadows C; Burnham EL; Moss M;
    Crit Care; 2013 May; 17(3):R92. PubMed ID: 23706007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the value of mitochondrial associated protein fumarylacetoacetate domain containing protein 1 and growth differentiation factor-15 in the diagnosis of sepsis: test results from the patients of a multicenter study].
    Li M; Ren R; Chen S; Chen C; Yan J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):180-185. PubMed ID: 33729137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth Differentiation Factor-15 Is Considered a Predictive Biomarker of Long COVID in Non-hospitalized Patients.
    Ono R; Takayama S; Abe M; Arita R; Abe T; Ishii T
    Cureus; 2024 May; 16(5):e59433. PubMed ID: 38826986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative plasma growth-differentiation factor-15 for prediction of acute kidney injury in patients undergoing cardiac surgery.
    Heringlake M; Charitos EI; Erber K; Berggreen AE; Heinze H; Paarmann H
    Crit Care; 2016 Oct; 20(1):317. PubMed ID: 27717384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
    Bozorgmehr N; Mashhouri S; Perez Rosero E; Xu L; Shahbaz S; Sligl W; Osman M; Kutsogiannis DJ; MacIntyre E; O'Neil CR; Elahi S
    mBio; 2021 May; 12(3):. PubMed ID: 33947753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Plasma GDF-15 for Diagnosis and Prognosis Assessment of ICU-Acquired Weakness in Mechanically Ventilated Patients: Prospective Observational Study.
    Xie Y; Liu S; Zheng H; Cao L; Liu K; Li X
    Biomed Res Int; 2020; 2020():3630568. PubMed ID: 32104689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.